This legislation directs the Department of Veterans Affairs and the Department of Defense to furnish stellate ganglion block (SGB) as a treatment option for eligible veterans and members of the Armed Forces diagnosed with post-traumatic stress disorder. To receive this therapy, individuals must be enrolled in their respective healthcare systems, have a confirmed PTSD diagnosis, and provide informed consent after understanding the risks and benefits. The bill mandates that both departments update their joint Clinical Practice Guideline for the Management of PTSD within 180 days to include SGB as a recognized therapy option, detailing its clinical indicators and contraindications. This ensures that SGB is integrated into official medical guidance and made accessible through departmental facilities or authorized external providers.